Pretraživanje
Prikaz rezultata 1-10 od 43
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice
(Rockville: American Society for Pharmacology and Experimental Therapeutics (ASPET), 2007)
Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients
(John Wiley and Sons, 2002)
Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: Clinical and histopathological evaluation
(New York, USA: Springer - Plenum publishers, 2008)
Macrophage migration inhibitory factor as potential therapeutic target for prevention and treatment of autoimmune diabetogenesis. Lessons from animal models
(International Journal of Molecular Medicine, 2009)
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
(Nitric Oxide-Biology and Chemistry, 2008)
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
(Molecular Cancer Therapeutics, 2008)